Adjuvant Chemotherapy in Patients with Neuroendocrine Carcinoma of the Urinary Tract

被引:0
|
作者
Nakajima, Hiromichi [1 ]
Kondoh, Chihiro [1 ]
Ozaki, Yukinori [1 ]
Tanabe, Yuko [1 ]
Miura, Yuji [1 ]
Sakaguchi, Kazushiige [2 ]
Uragami, Shinji [2 ]
Inoshita, Naoko [3 ]
Okaneya, Toshikazu [2 ]
Takano, Toshimi [1 ]
机构
[1] Toranomon Gen Hosp, Dept Med Oncol, Tokyo, Japan
[2] Toranomon Gen Hosp, Dept Urol, Tokyo, Japan
[3] Toranomon Gen Hosp, Dept Pathol, Tokyo, Japan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
O1-12-3
引用
收藏
页数:1
相关论文
共 50 条
  • [11] Clinical Outcomes of Systemic Chemotherapy in Patients with High Grade Neuroendocrine Carcinoma of Biliary Tract
    Yoo, C.
    Lee, K.
    Kim, K. P.
    Chang, H. M.
    Ryoo, B. Y.
    NEUROENDOCRINOLOGY, 2017, 105 : 189 - 189
  • [12] Cytomorphology of high-grade neuroendocrine carcinoma of the urinary tract
    Acs, G
    Gupta, PK
    Baloch, ZW
    DIAGNOSTIC CYTOPATHOLOGY, 2000, 23 (02) : 92 - 96
  • [13] Postoperative recurrence and the role of adjuvant chemotherapy in patients with pulmonary large-cell neuroendocrine carcinoma
    Iyoda, Akira
    Hiroshima, Kenzo
    Moriya, Yasumitsu
    Iwadate, Yasuo
    Takiguchi, Yuichi
    Uno, Takashi
    Nakatani, Yukio
    Yoshino, Ichiro
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2009, 138 (02): : 446 - 453
  • [14] Therapeutic benefit of adjuvant gemcitabine-cisplatin combination chemotherapy in the treatment of patients with invasive transitional cell carcinoma of the upper urinary tract
    Song, Y. S.
    Doe, S. H.
    Yun, J. H.
    Yang, W. J.
    Kim, C., I
    Kim, H. S.
    Song, K. H.
    Kim, S., I
    Kim, S. J.
    Lee, D. H.
    Cho, I. R.
    Seong, D. H.
    Cho, J. S.
    Kim, Y. S.
    Chun, S. H.
    Kim, D. J.
    Chung, B. H.
    Cho, K. S.
    Choi, Y. D.
    Hong, S. J.
    EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (03) : 221 - 221
  • [15] Adjuvant Radiotherapy With or Without Chemotherapy in Patients With Stage III/IV Transitional Cell Carcinoma of the Upper Urinary Tract And/or Positive Resection Margin
    Jwa, E.
    Kim, Y. S.
    Kim, C. S.
    Ahn, H.
    Lee, J. L.
    Lee, S. W.
    Kim, J. H.
    Choi, E. K.
    Ahn, S. D.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S511 - S512
  • [16] The Effectiveness of Off-Protocol Adjuvant Chemotherapy for Patients with Urothelial Carcinoma of the Urinary Bladder
    Svatek, Robert S.
    Shariat, Shahrokh F.
    Lasky, Robert E.
    Skinner, Eila C.
    Novara, Giacomo
    Lerner, Seth P.
    Fradet, Yves
    Bastian, Patrick J.
    Kassouf, Wassim
    Karakiewicz, Pierre I.
    Fritsche, Hans-Martin
    Mueller, Stefan C.
    Izawa, Jonathan I.
    Ficarra, Vincenzo
    Sagalowsky, Arthur I.
    Schoenberg, Mark P.
    Siefker-Radtke, Arlene O.
    Millikan, Randall E.
    Dinney, Colin P. N.
    CLINICAL CANCER RESEARCH, 2010, 16 (17) : 4461 - 4467
  • [17] Neoadjuvant and adjuvant chemotherapy use in upper tract urothelial carcinoma
    Cohen, Andrew
    Kuchta, Kristine
    Park, Sangtae
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2017, 35 (06) : 322 - 327
  • [18] Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma: Is There Sufficient Evidence?
    Biswas, Bivas
    Ganguly, Sandip
    Ghosh, Joydeep
    Prasad, E.
    Dabkara, Deepak
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (18) : 2095 - +
  • [19] Neoadjuvant versus adjuvant chemotherapy for upper tract urothelial carcinoma
    Martini, Alberto
    Falagario, Ugo Giovanni
    Waingankar, Nikhil
    Daza, Jorge
    Treacy, Patrick Julien
    Necchi, Andrea
    Galsky, Matthew D.
    Sfakianos, John P.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2020, 38 (08) : 684.e9 - 684.e15
  • [20] The efficacy and timing of adjuvant chemotherapy in upper tract urothelial carcinoma
    Li, Hailong
    Zhou, Jie
    Chen, Renfu
    Zhu, Jiawei
    Wang, Junqi
    Wen, Rumin
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (08) : 356e1 - 356e9